volume 27, issue 6, P803-807 2013
DOI: 10.3109/02688697.2013.793287
View full text
|
Sign up to set email alerts
|
Share

Abstract: In adults, mild traumatic brain injury (MTBI) frequently results in impairments of cognitive functions which would lead to psychological consequences in the future. Cerebrolysin is a nootropic drug, and can significantly improve cognitive function in patients with Alzheimer's disease and stroke. The purpose of this study was to investigate how Cerebrolysin therapy enhances cognitive recovery for mild traumatic brain injury patients using a double-blinded, placebo-controlled, randomized phase II pilot study. Pa…

Expand abstract